Form D · Biotechnology

PurCell Bio, Inc

Bozeman, MT · CIK 0002001594

Offering snapshot reported Mar 12, 2024 · SEC filing

Reported sold
$841K
Offering amount: $1.3M
Investors reported
25
Form D · investor count
Minimum accepted
$100
Reported outside-investor minimum
First sale
Aug 8, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$421K$841KJan 25, 2024: $695,000.00Jan 25, 2024Mar 12, 2024: $841,000.00Mar 12, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$695,000 → $841,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 12, 2024Amendment$841,000$146,000vs Jan 25, 202425SEC filing
Jan 25, 2024Initial$695,000No comparison25SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-503491

Source: Form D, filed Mar 12, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Elizabeth D Corbin Executive
Eric Jacobs Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
770 Osterman Drive Unit B
Bozeman, MT, 59715